Our previous work has shown the involvement of MMP-3, MMP-9, TIMP-3, and TIMP-4 in response to radiotherapy in breast cancer patients, suggesting their utility as potential prognostic and predictive biomarkers for this pathology [24]. This evidence concerns the gene TIMP3 and breast cancer.